Published: 22 May 2023
Author(s): B. Villanueva, P. Cerdà, R. Torres-Iglesias, J.L. Rocamora, A. Figueras, F. Viñals, A. Riera-Mestre
Section: Review Article

Vascular diseases are the main cause of death in developed countries [1]. Despite much progress has been made to improve the management of these diseases, it is difficult to predict those patients at high risk of mortality. Biomarkers are a relatively new clinical toolset used in the current precision medicine approach. This is a medical model that proposes the customization of healthcare, with medical decisions, treatments or practices being tailored to a subgroup of patients, instead of a “one-drug-fits-all” model.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.